Physician Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$124K Buy
295
+60
+26% +$23.9K 0.01% 297
2026
Q2
$85.1K Buy
235
+5
+2% +$1.71K 0.01% 338
2026
Q1
$80.9K Buy
230
+22
+11% +$7.84K 0.01% 313
2025
Q4
$68.1K Buy
208
+86
+70% +$27.3K 0.01% 331
2025
Q3
$34.4K Sell
122
-5
-4% -$1.45K ﹤0.01% 450
2025
Q2
$35.5K Buy
127
+5
+4% +$1.42K 0.01% 399
2025
Q1
$38K Buy
122
+7
+6% +$2.07K 0.01% 373
2024
Q4
$30K Buy
+115
New +$34.1K 0.01% 429

Other funds holding AMGN

Physician Wealth Advisors's AMGN Position: Q3 2026 in Review

Physician Wealth Advisors increased its Amgen (AMGN) stake by 26% in Q3 2026, buying an estimated $23.9K and bringing the position to 295 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #297.

Physician Wealth Advisors first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Physician Wealth Advisors held 295 shares of Amgen worth $124K as of Q3 2026.
  • Physician Wealth Advisors bought 60 Amgen shares in Q3 2026, an estimated $23.9K.
  • Amgen made up 0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #297 holding.
  • Physician Wealth Advisors first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.